Risk Assessment Approach to Microbiological Controls of Cellular Therapies

Anthony M Cundell; Don Singer; Irving Ford; Scott Drummond; Dona Reber

doi:10.5731/pdajpst.2019.010546

OtherTechnology/Application

Risk Assessment Approach to Microbiological Controls of Cellular Therapies

Anthony M Cundell, Don Singer, Irving Ford, Scott Drummond and Dona Reber

PDA Journal of Pharmaceutical Science and Technology January 2020, pdajpst.2019.010546; DOI: https://doi.org/10.5731/pdajpst.2019.010546

Anthony M Cundell

1 Independent Consultant;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: tonycundell@gmail.com

Don Singer

2 GSK;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: donald.c.singer@gsk.com

Irving Ford

3 Celgene;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: iford@celgene.com

Scott Drummond

4 J&J;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dona Reber

5 Pfizer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: dona.reber@pfizer.com

Article
References
Info & Metrics
PDF

Article Information

pdajpst.2019.010546

DOI

https://doi.org/10.5731/pdajpst.2019.010546

PubMed

31941793

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Received July 30, 2019
Accepted December 10, 2019
Published online January 15, 2020.

Article Versions

You are currently viewing a previous version of this article (January 15, 2020 - 07:38).
View the most recent version of this article

Author Information

Anthony M Cundell1,6 (tonycundell{at}gmail.com),
Don Singer2 (donald.c.singer{at}gsk.com),
Irving Ford3 (iford{at}celgene.com),
Scott Drummond4 and
Dona Reber5 (dona.reber{at}pfizer.com)

¹ Independent Consultant;
² GSK;
³ Celgene;
⁴ J&J;
⁵ Pfizer

↵* Corresponding author; email: tonycundell{at}gmail.com

Cited By...

3 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Comprehensive Study Identifies a Sensitive, Low-Risk, Closed-System Model for Detection of Fungal Contaminants in Cell and Gene Therapy Products

Nicole E. Putnam, Anna F. Lau, Kimberly E. Hanson

Journal of Clinical Microbiology 2021 59 11
Differentiation of human pluripotent stem cells into insulin-producing islet-like clusters using nanofiltered cell culture medium

Julia Thorngren, Svitlana Vasylovska, Jules Blanc, Lulu Wu, Levon Manukyan, Albert Mihranyan, Joey Lau

Frontiers in Membrane Science and Technology 2024 3
Report of a clinical and laboratory management of cell therapy for knee cartilage in the face of mycoplasma contamination

Alessandro Rozim Zorzi, Eliane Antonioli, Juliana Aparecida Preto de Godoy, Oswaldo Keith Okamoto, Andrea Tiemi Kondo, José Mauro Kutner, Camila Cohen Kaleka, Moisés Cohen, Mario Ferretti

einstein (São Paulo) 2022 20

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 78, Issue 4

July/August 2024

Table of Contents
Index by Author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Risk Assessment Approach to Microbiological Controls of Cellular Therapies

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 20 + 0 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Risk Assessment Approach to Microbiological Controls of Cellular Therapies

Anthony M Cundell, Don Singer, Irving Ford, Scott Drummond, Dona Reber

PDA Journal of Pharmaceutical Science and Technology Jan 2020, pdajpst.2019.010546; DOI: 10.5731/pdajpst.2019.010546

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Risk Assessment Approach to Microbiological Controls of Cellular Therapies

Anthony M Cundell, Don Singer, Irving Ford, Scott Drummond, Dona Reber

PDA Journal of Pharmaceutical Science and Technology Jan 2020, pdajpst.2019.010546; DOI: 10.5731/pdajpst.2019.010546

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Contamination Control Strategy: Implementation Road Map

Google Scholar

Keywords

Microbial contamination
Risk-based Approach

Main menu

User menu

Search

Risk Assessment Approach to Microbiological Controls of Cellular Therapies

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.